biotech · Clostridium Difficile Infection · Autism Spectrum Disorder · FNCHQ
Finch Therapeutics Group
Finch Therapeutics Group patent portfolio — 33 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Somerville, USA
- Employees
- 15
- Programs
- 5
- Drugs
- 2
- Patents
- 33
Finch Therapeutics Group patents
33 pharmaceutical patents indexed for Finch Therapeutics Group. 0 expire within 24 months.
Finch Therapeutics Group has 33 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12390496
Methods for treating ulcerative colitis
granted -
US 12350298
Microbiome related immunotherapies
granted -
US 12290538
Methods and products for treatment of gastrointestinal disorders
granted -
US 12285447
Methods and compositions for treating ulcerative colitis
granted -
US 12161678
Compositions for fecal floral transplantation and methods for making and using them and device for delivering them
granted -
US 12005086
Microbiome related immunotherapies
granted -
US 11911419
Compositions and methods for treating epilepsy and related disorders
granted -
US 11890307
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11890306
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
granted -
US 11890308
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11865145
Compositions and methods for maintaining and restoring a healthy gut barrier
granted -
US 11850269
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11623930
Imidazodiazepinediones and methods of use thereof
granted -
US 11541080
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11529375
Compositions and methods for treating diverticulitis and related disorders
granted -
US 11504403
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11491193
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11433102
Compositions and methods for treating Parkinson's disease (PD) and related disorders
granted -
US 11351205
Microbiome related immunotherapies
granted -
US 11213549
Compositions and method for treating primary sclerosing cholangitis and related disorders
granted -
US 11207356
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11173183
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11166990
Methods and compositions for treating ulcerative colitis
granted -
US 11129859
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11123377
Compositions for fecal floral transplantation and methods for making and using them and device for delivering them
granted -
US 11103541
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11071759
Methods for treating ulcerative colitis
granted -
US 11065284
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11046690
Pyridazinones and methods of use thereof
granted -
US 11040073
Compositions and methods for treating diverticulitis and related disorders
granted -
US 11026978
Compositions and methods for treating multiple sclerosis and related disorders
granted -
US 10987385
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 10654850
Pyridazinones and methods of use thereof
granted
Frequently asked questions
How many patents does Finch Therapeutics Group have?
33 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Finch Therapeutics Group patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.